MARVELD2 and breast cancer: Indeed, TRiC subunits are significantly associated with aggressive cancer traits and poor outcomes in hepatocellular carcinoma [47], Ewing sarcoma [48], breast cancer [49, 50], neuroblastoma [51], gastric cancer [52], and lung adenocarcinoma [53].